fragile X syndrome

Under the collaboration, Asuragen will develop diagnostic kits for analyzing repeat sequences using Thermo Fisher's 3500 Dx Series Genetic Analyzer CS2 instrument.

Under a five-year NIH grant, the researchers will evaluate whether earlier diagnosis of fragile X and SMA leads to earlier intervention and improved outcomes.

The firm, which makes both neurogenetic and oncology diagnostics, also provided updates on its market strategies and menu outlook.

London Health Sciences Center researchers published a study validating the accuracy of the method as a potential screening test for symptomatic male patients.

A suite of assays published today in The Journal of Molecular Diagnostics tackles issues with genetic testing, making it more robust and affordable. 

A team at UC Davis is developing a method to sequence the FMR1 gene on the PacBio platform and determine its methylation status at the same time.

At Scientific American Mind, a family shares its story of fragile X syndrome.

NEW YORK (GenomeWeb) – Emory University researchers have received a roughly $8 million grant from the National Institutes of Health to fund a study that will use whole-genome sequencing to investigate modifier genes that predispose people with FMR1 gene mutations to specific clinical outcomes.

NEW YORK (GenomeWeb) — Scientists from Asuragen and the New York Institute for Basic Research in Development Disabilities have published research that they claim provides the most compelling evidence to date for a relationship between AGG sequence interruptions and the risk of triplet repeat expa

NEW YORK (GenomeWeb) – Asuragen today announced it has received a clinical laboratory permit from New York state to offer the company's Xpansion Interpreter and miRInform Thyroid tests in the state.

Pages

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.